The monitoring of chimerism has become a routine diagnostic instrument at centers
performing allogeneic stem cell or bone marrow transplantation. Despite the widespread …

Conventional analysis of host chimerism (HC) frequently fails to detect relapse before its
clinical manifestation in patients with hematological malignancies after allogeneic stem cell …

In acute myeloid leukemia (AML), the selection of poor‐risk patients for allogeneic
hematopoietic stem cell transplantation (HSCT) is associated with rather high post …

Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …

Background Acute lymphoblastic leukemia (ALL) remains one of the most difficult-to-cure
hematological malignancies. Allogeneic hematopoietic stem cell transplantation (HSCT) …

The utility of routine chimerism analysis as a prognostic indicator of subsequent outcomes
after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning …

We compared the results of chimerism analyses with real‐time SNP‐PCR to those obtained
by the classical STR‐PCR method in 135 hematopoietic stem cell transplantation recipients …

This retrospective study aimed to analyse the impact on overall survival (OS) and event‐free
survival (EFS) of chimaerism status and kinetics following allogeneic conventional and …

In the light of reduced intensity conditioning regimens for allogeneic transplantation,
monitoring of donor cell engraftment acquires new relevance. We analysed the clinical …

Chimerism analysis has become an important tool for the peri-transplant surveillance of
engraftment. It offers the possibility to realize impending graft rejection and can serve as an …